Dynamics of epithelial–mesenchymal plasticity driving cancer drug resistance
Epithelial–mesenchymal transition (EMT) promotes several cancers by increasing tumor cell motility, disrupting epithelial cell phenotypes, apical–basal polarity, and intracellular connections, and enhancing tumor resistance to immunotherapy and chemotherapy. Mesenchymal–epithelial transition (MET),...
Saved in:
| Main Authors: | Rashmi Bangarh, Reena V. Saini, Adesh K. Saini, Tejveer Singh, Hemant Joshi, Seema Ramniwas, Moyad Shahwan, Hardeep Singh Tuli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | Cancer Pathogenesis and Therapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2949713224000533 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The interplay of autophagy and epithelial-to-mesenchymal transition in cancer progression
by: O. O. Ryabaya, et al.
Published: (2020-09-01) -
Epithelial–Mesenchymal Transition in Non-Small Cell Lung Cancer Management: Opportunities and Challenges
by: Yunyao Ye, et al.
Published: (2024-11-01) -
Vitronectin promotes proliferation and metastasis of cervical cancer cells via the epithelial-mesenchymal transition
by: Yao Lin, et al.
Published: (2024-12-01) -
Epithelial-mesenchymal transition orchestrates tumor microenvironment: current perceptions and challenges
by: Yuqi Xie, et al.
Published: (2025-04-01) -
Epigenetic Changes Regulating Epithelial–Mesenchymal Plasticity in Human Trophoblast Differentiation
by: William E. Ackerman IV, et al.
Published: (2025-06-01)